1.
Wasel N, Dutronc Y, Schinzel B, Lacour J-P. Comparison of Ixekizumab and Ustekinumab Efficacy in the Treatment of Nail Lesions of Patients With Moderate-to-Severe Plaque Psoriasis: 52-Week Data From the IXORA-S Trial. J of Skin [Internet]. 2018Dec.17 [cited 2024Jul.22];2:S117. Available from: https://jofskin.org/index.php/skin/article/view/499